Connect with us

Hi, what are you looking for?

Investing

AbbVie on track for biggest decline in about three years as newer drug sales lag estimates

Shares of AbbVie Inc. tumbled 8% Thursday, after the biopharmaceutical company missed first-quarter profit expectations, as some of its newer drugs missed their revenue targets while blockbuster Humira lost ground to biosimilars.

The stock was on track for its biggest one-day percentage decline since March of 2020 and was second worst performer on the S&P 500 after Align Technology Inc. ALGN

Humira,…

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Genesco Inc. (NYSE:GCO) Q3 2025 Earnings Conference Call December 6, 2024 8:30 AM ET Company Participants Darryl MacQuarrie – Senior Director of FP&AMimi Vaughn...

News

Listen below or on the go on Apple Podcasts and Spotify Handling market volatility with long-term dividend growth investing. Prioritizing future dividends over immediate...

News

This article was written by Follow Cash Builder Opportunities (aka Nick Ackerman) is a former fiduciary and a registered financial advisor with 14 years...

News

This article was written by Follow True Orion is comprised of two notions. Orion, the ancient mythical hunter, and truth. The neverending pursuit for...